Milan, 12th November 2025 – Today, at the Godard Cinema of Fondazione Prada in Milan, the opening press conference of the “Joint International Conference 2025: Innovation in Oncology – New Drugs and the Impact of Artificial Intelligence” was held. The event is organized by Fondazione Gianni Bonadonna with the support of Prada Group, Fondazione Michelangelo, and the European School of Oncology. Scheduled for November 12–13, 2025, this international event brings together leading global experts in oncology – clinicians and researchers – for two intensive days dedicated to innovation in cancer research and care. The scientific program will address two major challenges in contemporary oncology research: on one hand, the latest frontiers in drug development and therapeutic strategies to overcome tumor resistance mechanisms; on the other, the growing impact of Artificial Intelligence in precision medicine. During the press conference, ongoing and future initiatives resulting from the collaboration between Fondazione Gianni Bonadonna and Prada Group were also presented, starting with the recent launch of the “Concerted Research Institute”. A central focus is also placed on training and empowering the next generation of researchers, with the announcement of the continuation of the “Gianni Bonadonna Fellowship”.